{"transactions":[{"id":1025,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:20:38.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":10736,"source":{"system":"sec-edgar","filing":"0001754371-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754371/000175437126000007/edgardoc.xml","form_type":"4"}},{"id":1024,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:20:38.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.0643,"value":3416.9002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":12428,"source":{"system":"sec-edgar","filing":"0001754371-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754371/000175437126000007/edgardoc.xml","form_type":"4"}},{"id":692944,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:44:10.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":12442,"source":{"system":"sec-edgar","filing":"0001754371-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175437126000004/edgardoc.xml","form_type":"4"}},{"id":710627,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":17167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":0,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":17167},"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710626,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":112422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":0,"derivative":{"exercise_price":29,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":112422},"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710625,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":0,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710624,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":112422,"price":90,"value":10117980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":8383,"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710623,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":36167,"price":84,"value":3038028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":120805,"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710622,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":17167,"price":16.75,"value":287547.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":156972,"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710621,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":112422,"price":29,"value":3260238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":139805,"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":710620,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:40:35.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":19000,"price":8.45,"value":160550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":27383,"source":{"system":"sec-edgar","filing":"0001470831-26-000708","document":"wk-form4_1783975232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000708/wk-form4_1783975232.xml","form_type":"4"}},{"id":727733,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":17167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":17167,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":17167},"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727732,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":19000,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727731,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-22","kind":"grant","planned":true,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."}],"balance_after":5277,"derivative":{"exercise_price":68.92,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727730,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":37167,"price":70,"value":2601690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":8383,"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727729,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":17167,"price":16.75,"value":287547.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":45550,"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727728,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.45,"value":169000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":28383,"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727727,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":2196,"price":68.57,"value":150579.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":8383,"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":727726,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:29.000Z","date":"2026-06-22","kind":"grant","planned":true,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":10579,"source":{"system":"sec-edgar","filing":"0001470831-26-000636","document":"wk-form4_1782338786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000636/wk-form4_1782338786.xml","form_type":"4"}},{"id":734175,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":17167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":34334,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":17167},"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":734174,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":65921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":39000,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":65921},"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":734173,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1503,"price":67.1425,"value":100915.1775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $67.10 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":6589,"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":734172,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":88737,"price":66.6153,"value":5911241.8761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $66.10 to $67.095 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":8092,"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":734171,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":17167,"price":16.75,"value":287547.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":96829,"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":734170,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:45:11.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":65921,"price":8.45,"value":557032.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026."}],"balance_after":79662,"source":{"system":"sec-edgar","filing":"0001470831-26-000550","document":"wk-form4_1781729104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000550/wk-form4_1781729104.xml","form_type":"4"}},{"id":748019,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:43:24.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":19226,"derivative":{"exercise_price":19.66,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19226},"source":{"system":"sec-edgar","filing":"0001754371-26-000002","document":"wk-form4_1780692201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000175437126000002/wk-form4_1780692201.xml","form_type":"4"}},{"id":748018,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:43:24.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":6408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one\nyear anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,408 unvested RSUs."}],"balance_after":32483,"source":{"system":"sec-edgar","filing":"0001754371-26-000002","document":"wk-form4_1780692201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000175437126000002/wk-form4_1780692201.xml","form_type":"4"}},{"id":1069969,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:47:29.000Z","date":"2025-08-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1805,"price":111.2494,"value":200805.167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":10837,"source":{"system":"sec-edgar","filing":"0001765581-25-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000094/edgardoc.xml","form_type":"4"}},{"id":1069968,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:47:29.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":3507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":12642,"source":{"system":"sec-edgar","filing":"0001765581-25-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000094/edgardoc.xml","form_type":"4"}},{"id":1102696,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T23:10:56.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089670/ownership.xml","form_type":"4"}},{"id":1102695,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T23:10:56.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":13741,"source":{"system":"sec-edgar","filing":"0000950170-25-089670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089670/ownership.xml","form_type":"4"}},{"id":1121382,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T20:34:17.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":18111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":18111,"derivative":{"exercise_price":13.93,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":18111},"source":{"system":"sec-edgar","filing":"0001714899-25-000142","document":"wk-form4_1749155629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489925000142/wk-form4_1749155629.xml","form_type":"4"}},{"id":1121381,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:34:17.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":6037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,037 unvested RSUs."}],"balance_after":26075,"source":{"system":"sec-edgar","filing":"0001714899-25-000142","document":"wk-form4_1749155629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489925000142/wk-form4_1749155629.xml","form_type":"4"}},{"id":1439500,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:39:20.000Z","date":"2024-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1484,"price":111.35,"value":165243.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9135,"source":{"system":"sec-edgar","filing":"0001765581-24-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000073/edgardoc.xml","form_type":"4"}},{"id":1439499,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:39:20.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":3731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025."}],"balance_after":10619,"source":{"system":"sec-edgar","filing":"0001765581-24-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000073/edgardoc.xml","form_type":"4"}},{"id":1469555,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:35:38.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024077440/ownership.xml","form_type":"4"}},{"id":1484982,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T00:06:11.000Z","date":"2024-06-06","kind":"sale","planned":true,"acquired":false,"shares":1458,"price":21.73,"value":31682.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,967 unvested RSUs."}],"balance_after":20038,"source":{"system":"sec-edgar","filing":"0001714899-24-000145","document":"wk-form4_1718064363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489924000145/wk-form4_1718064363.xml","form_type":"4"}},{"id":1492397,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-04T22:30:09.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":17901,"derivative":{"exercise_price":18.56,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001714899-24-000137","document":"wk-form4_1717540199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489924000137/wk-form4_1717540199.xml","form_type":"4"}},{"id":1492396,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T22:30:09.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,967 unvested RSUs."}],"balance_after":21496,"source":{"system":"sec-edgar","filing":"0001714899-24-000137","document":"wk-form4_1717540199.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489924000137/wk-form4_1717540199.xml","form_type":"4"}},{"id":1719935,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-12-06T21:31:48.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":417,"price":119.27,"value":49735.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6888,"source":{"system":"sec-edgar","filing":"0001765581-23-000108","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000108/edgardoc.xml","form_type":"4"}},{"id":1807120,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:44:24.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":1241,"price":138.1581,"value":171454.2021,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.69 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001765581-23-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000076/edgardoc.xml","form_type":"4"}},{"id":1807119,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:44:24.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":8546,"source":{"system":"sec-edgar","filing":"0001765581-23-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000076/edgardoc.xml","form_type":"4"}},{"id":1845281,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:15:32.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123039347/doc4.xml","form_type":"4"}},{"id":1867185,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T22:04:59.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":12649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":12649,"derivative":{"exercise_price":30.92,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":12649},"source":{"system":"sec-edgar","filing":"0001714899-23-000097","document":"wk-form4_1686002689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489923000097/wk-form4_1686002689.xml","form_type":"4"}},{"id":1867184,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:04:59.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,216 unvested RSUs."}],"balance_after":15529,"source":{"system":"sec-edgar","filing":"0001714899-23-000097","document":"wk-form4_1686002689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489923000097/wk-form4_1686002689.xml","form_type":"4"}},{"id":2003681,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:19:37.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% vested on November 16, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% vested on November 16, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001209191-23-011455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123011455/doc4.xml","form_type":"4"}},{"id":2003680,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T01:19:37.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":3576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":7152,"source":{"system":"sec-edgar","filing":"0001209191-23-011455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123011455/doc4.xml","form_type":"4"}},{"id":2094290,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-12-07T00:01:35.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":420,"price":154.6799,"value":64965.558,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":5471,"source":{"system":"sec-edgar","filing":"0001765581-22-000132","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000132/edgardoc.xml","form_type":"4"}},{"id":2190625,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:09:23.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1089,"price":152.3227,"value":165879.4203,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":5891,"source":{"system":"sec-edgar","filing":"0001765581-22-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000082/edgardoc.xml","form_type":"4"}},{"id":2190624,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:09:23.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":6980,"source":{"system":"sec-edgar","filing":"0001765581-22-000082","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000082/edgardoc.xml","form_type":"4"}},{"id":2222109,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:25:22.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122039232/doc4.xml","form_type":"4"}},{"id":2242442,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-07T00:08:24.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":17959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":17959,"derivative":{"exercise_price":24.27,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":17959},"source":{"system":"sec-edgar","filing":"0001714899-22-000093","document":"wf-form4_165456048293686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489922000093/wf-form4_165456048293686.xml","form_type":"4"}},{"id":2242441,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:08:24.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":5986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,986 unvested restricted stock units."}],"balance_after":11313,"source":{"system":"sec-edgar","filing":"0001714899-22-000093","document":"wf-form4_165456048293686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000171489922000093/wf-form4_165456048293686.xml","form_type":"4"}},{"id":2483547,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-12-07T00:13:56.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":417,"price":121.3,"value":50582.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":4419,"source":{"system":"sec-edgar","filing":"0001765581-21-000131","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000131/edgardoc.xml","form_type":"4"}},{"id":2619818,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:09:12.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":4836,"source":{"system":"sec-edgar","filing":"0001765581-21-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000067/edgardoc.xml","form_type":"4"}},{"id":2658955,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T23:03:42.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":38895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":38895,"derivative":{"exercise_price":62.63,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":38895},"source":{"system":"sec-edgar","filing":"0000899243-21-025381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321025381/doc4.xml","form_type":"4"}},{"id":2681033,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T22:32:32.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":6222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":6222,"derivative":{"exercise_price":63.76,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":6222},"source":{"system":"sec-edgar","filing":"0001209191-21-038376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919121038376/doc4.xml","form_type":"4"}},{"id":2681032,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T22:32:32.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":2074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":5327,"source":{"system":"sec-edgar","filing":"0001209191-21-038376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919121038376/doc4.xml","form_type":"4"}},{"id":2683426,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-04T00:52:37.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":3253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3253},"source":{"system":"sec-edgar","filing":"0001209191-21-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919121038036/doc4.xml","form_type":"4"}},{"id":2683425,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T00:52:37.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":3253,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3253,"source":{"system":"sec-edgar","filing":"0001209191-21-038036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919121038036/doc4.xml","form_type":"4"}},{"id":2825847,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-01T21:56:07.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest 1/3 on December 1, 2021 and in 24 equal monthly installments thereafter."}],"balance_after":6475,"derivative":{"exercise_price":170.74,"expiration_date":"2031-02-24","underlying":"Ordinary Shares","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001765581-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000009/edgardoc.xml","form_type":"4"}},{"id":2825846,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-01T21:56:07.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":2590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in equal annual installments over three years measured from the vesting commencement date of December 1, 2020, with 1/3 vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent two years."}],"balance_after":2590,"source":{"system":"sec-edgar","filing":"0001765581-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000009/edgardoc.xml","form_type":"4"}},{"id":2975442,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-11-19T00:38:57.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% will vest on November 16, 2021, subject to the Reporting Person's continuous service with the Issuer through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% will vest on November 16, 2021, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":3576,"derivative":{"underlying":"Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0000899243-20-031548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031548/doc4.xml","form_type":"4"}},{"id":2975441,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T00:38:57.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":3576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":3576,"source":{"system":"sec-edgar","filing":"0000899243-20-031548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320031548/doc4.xml","form_type":"4"}},{"id":3120551,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-05T21:59:24.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":3253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":3253,"derivative":{"underlying":"Common Stock","underlying_shares":3253},"source":{"system":"sec-edgar","filing":"0001209191-20-034765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919120034765/doc4.xml","form_type":"4"}},{"id":3120550,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-05T21:59:24.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":15183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date."}],"balance_after":15183,"derivative":{"exercise_price":28.82,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":15183},"source":{"system":"sec-edgar","filing":"0001209191-20-034765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919120034765/doc4.xml","form_type":"4"}},{"id":3122274,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-04T23:23:41.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":112422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":112422,"derivative":{"exercise_price":29,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":112422},"source":{"system":"sec-edgar","filing":"0000899243-20-015308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015308/doc4.xml","form_type":"4"}},{"id":3341079,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-17T01:59:55.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":82878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after December 12, 2019, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":82878,"derivative":{"exercise_price":37.45,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":82878},"source":{"system":"sec-edgar","filing":"0000899243-19-029347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319029347/doc4.xml","form_type":"4"}},{"id":3506521,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-31T22:34:56.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":27245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date."}],"balance_after":27245,"derivative":{"exercise_price":19.5,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":27245},"source":{"system":"sec-edgar","filing":"0001209191-19-033735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919119033735/doc4.xml","form_type":"4"}},{"id":3770670,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-08T22:37:45.000Z","date":"2018-11-06","kind":"grant","acquired":true,"shares":50044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on November 6, 2019, and an additional 1/48 of the shares subject to the option vest each month thereafter."}],"balance_after":50044,"derivative":{"exercise_price":17.08,"expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":50044},"source":{"system":"sec-edgar","filing":"0001209191-18-057789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714899/000120919118057789/doc4.xml","form_type":"4"}}]}